NCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
Clinical Trials
98 trialsNCT07450833 2026-03-05
BOOST
Benfovir AG
Phase 1 Completed
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT07328399 2026-01-09
Impact of COVID-19 Pandemic Waves on Colorectal Cancer Stage Migration and Diagnostic Delays
University of Pecs
Completed
NCT04872738 2026-01-06
LymphVAX
Massachusetts General Hospital
Completed
NCT04442048 2025-12-30
COV-IMMUNO
Canadian Cancer Trials Group
Phase 3 Completed
NCT04425616 2025-12-02
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer
University Hospital Southampton NHS Foundation Trust
Phase NA Completed
NCT04830046 2025-11-26
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Massachusetts General Hospital
Completed
NCT04492410 2025-09-30
NEOSCREENCOVID
Centre Antoine Lacassagne
Phase NA Completed
NCT04427280 2025-09-04
CARDS
Royal Marsden NHS Foundation Trust
Completed
NCT05120869 2025-09-04
Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention
University of Texas, El Paso
Phase NA Completed
NCT04932863 2025-08-08
UNICO
Ente Ospedaliero Ospedali Galliera
Completed
NCT04870333 2025-06-20
PROTECT-V
Cambridge University Hospitals NHS Foundation Trust
Phase 2/3 Completed
NCT04848493 2025-06-13
VAX4FRAIL
Azienda USL Reggio Emilia - IRCCS
Completed
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT04854980 2025-03-30
Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients
University of Rochester
Completed
NCT05386355 2025-03-11
MoVeUP
IDeA States Pediatric Clinical Trials Network
Phase NA Completed
NCT04683744 2025-01-31
Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation
Indiana University
Completed
NCT04466098 2025-01-29
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT06469138 2025-01-29
8479217
BerGenBio ASA
Phase 1 Completed
NCT04865133 2024-12-10
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
Mayo Clinic
Completed
NCT05148806 2024-12-09
MELODY
Imperial College London
Completed
NCT06638957 2024-10-15
Impact of the COVID-19 Pandemic on Oncologic Outcomes in Colorectal Cancer
Asan Medical Center
Completed
NCT05058339 2024-09-19
Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
M.D. Anderson Cancer Center
Completed
NCT05690009 2024-08-29
AURA
Eurasian Association of Therapists
Completed
NCT04382495 2024-08-28
The Impact of COVID-19 Pandemic on Cancer Care
El Zaitoun Specialized Hospital
Completed
NCT05422937 2024-05-22
SPLaT-19
Keele University
Completed
NCT04953065 2024-05-09
Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients
Milton S. Hershey Medical Center
Completed
NCT04538456 2024-04-24
Impact of COVID-19 on Lung Cancer Patients
The Christie NHS Foundation Trust
Completed
NCT04666025 2024-04-08
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
Completed
NCT04487639 2024-02-16
FERTICOVID
University Hospital, Clermont-Ferrand
Phase NA Completed
NCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT05594147 2023-11-07
ROCURS
Bayer
Completed
NCT04695379 2023-10-06
CO-MY-COVID
University Hospital, Bordeaux
Completed
NCT05080920 2023-09-21
OnCOVInf
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
Phase NA Completed
NCT05303376 2023-09-13
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
Immune Biosolutions Inc
Phase 1/2 Completed
NCT04852796 2023-08-30
HEMVACO
Centre Hospitalier de Cornouaille
Completed
NCT04534725 2023-08-24
C-SMART
Peter MacCallum Cancer Centre, Australia
Phase 3 Completed
NCT05827341 2023-06-18
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
Sun Yat-sen University
Completed
NCT05062525 2023-05-09
VIVACIOUS
University Health Network, Toronto
Completed
NCT05226416 2023-05-09
ACTIV4
Eurasian Association of Therapists
Completed
NCT04445402 2023-05-03
Pediatrics HOT COVID-19 Database in NY Tristate
Columbia University
Completed
NCT04616950 2023-04-27
KOVID
Fondation Hôpital Saint-Joseph
Completed
NCT04397614 2023-04-24
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
University of Oklahoma
Phase NA Completed
NCT05054218 2023-04-14
COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT04910295 2023-04-12
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
Seoul National University Hospital
Completed
NCT04800146 2023-03-23
A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study
Oncology Institute of Southern Switzerland
Completed
NCT04844697 2023-03-01
RELOAD
Istituto Ortopedico Rizzoli
Completed
NCT04548531 2023-02-22
Engaging Patients in Colon Cancer Screening Decisions During COVID-19
Massachusetts General Hospital
Phase NA Completed